Ads
related to: novartis ag company- What Is TREMFYA®
Get Info On TREMFYA®
Learn More Today
- TREMFYA® Patient Support
Questions About Getting or Staying
on TREMFYA®? We Have Your Answers.
- TREMYFA® Dosing Timeline
Learn About a Dosing Schedule
and Administration Options.
- How TREMFYA® Works
Learn About TREMFYA®
Get Safety & Product Info.
- Treatment Cost Support
See Treatment Support Resources For
Questions About Costs, Dosing, etc.
- Visit Physician Website
Are You a Healthcare Professional?
Find HCP-Specific Information.
- What Is TREMFYA®
Search results
SageView Advisory Group LLC Acquires 718 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 8 hours agoSageView Advisory Group LLC boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 30.6% in the fourth quarter, according to the
Calliditas Therapeutics’ stock surges after $1.1 billion takeover bid
Market Watch· 3 hours agojumped more than 70% premarket on Tuesday after a nearly $1.1 billion takeover bid from Japanese...
Exploring Swiss Dividend Stocks In May 2024
Simply Wall St. via Yahoo Finance· 12 hours agoIn recent trading, the Swiss market demonstrated resilience, with the benchmark SMI index closing modestly higher after a day of fluctuating gains and...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 4 days agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
Major drug companies caught up in Cencora data loss
The Register· 2 days agoThe $250-billion firm – formerly known as AmerisourceBergen – partners with some of the largest pharma dealers, including GlaxoSmithKline, Novartis,...
Is Vanguard International Dividend Appreciation ETF (VIGI) a Strong ETF Right Now?
Zacks via Yahoo Finance· 1 day agoPerformance and Risk The ETF has added about 2.75% and is up about...78 and standard deviation of...
Ambivalent about big M&A, biotech Cytokinetics makes moves to raise $1 billion - San Francisco...
The Business Journals· 6 days agoNovartis AG, Johnson & Johnson and AstraZeneca have been reported since the start of the year to be...
Exploring Three Swiss Dividend Stocks With Yields Up To 4.6%
Simply Wall St. via Yahoo Finance· 1 day agoThe Switzerland market recently displayed a downturn, influenced by ongoing concerns about U.S....
Cystic fibrosis: global clinical trials landscape and treatments
Pharmaceutical Technology via Yahoo Finance· 4 days agoAffecting more than 162,000 patients worldwide, cystic fibrosis affects respiratory health and...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 5 days agoMorphoSys AG originally developed felzartamab for treating multiple myeloma. MorphoSys AG is due to...
